These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36177738)

  • 41. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
    Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
    J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
    DuBois J; Dover JS; Jones TM; Weiss RA; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):308-316. PubMed ID: 29537449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Prospective Randomized Controlled Pilot Study to Assess the Response and Tolerability of Cold Atmospheric Plasma for Rosacea.
    Hofmeyer S; Weber F; Gerds S; Emmert S; Thiem A
    Skin Pharmacol Physiol; 2023; 36(4):205-213. PubMed ID: 37490882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.
    Schaller M; Dirschka T; Lonne-Rahm SB; Micali G; Stein Gold LF; Tan J; Del Rosso J
    Acta Derm Venereol; 2021 Oct; 101(10):adv00584. PubMed ID: 34643244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosacea: Common Questions and Answers.
    Frazier W; Zemtsov RK; Ge Y
    Am Fam Physician; 2024 Jun; 109(6):533-542. PubMed ID: 38905551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical ivermectin 1.0% cream in the treatment of ocular demodicosis.
    Smith M; Wolffsohn JS; Chiang JCB
    Cont Lens Anterior Eye; 2024 Feb; 47(1):102099. PubMed ID: 38049351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA).
    George R; Gallo RL; Cohen JL; Brown M; Okeke CAV; Byrd AS
    J Drugs Dermatol; 2023 Jun; 22(6):546-553. PubMed ID: 37276169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial.
    Dall'Oglio F; Tedeschi A; Lacarrubba F; Fabbrocini G; Skroza N; Chiodini P; Micali G
    J Cosmet Dermatol; 2021 Apr; 20 Suppl 1(Suppl 1):28-31. PubMed ID: 33934475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New developments in the treatment of rosacea - role of once-daily ivermectin cream.
    Cardwell LA; Alinia H; Moradi Tuchayi S; Feldman SR
    Clin Cosmet Investig Dermatol; 2016; 9():71-7. PubMed ID: 27051311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life.
    Tan SR; Tope WD
    J Am Acad Dermatol; 2004 Oct; 51(4):592-9. PubMed ID: 15389196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.
    Steinhoff M; Schmelz M; Schauber J
    Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical metronidazole maintains remissions of rosacea.
    Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
    Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea.
    Ortiz A; Elkeeb L; Truitt A; Hindiyeh R; Aquino L; Tran M; Weinstein G
    J Drugs Dermatol; 2009 May; 8(5):459-62. PubMed ID: 19537369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical metronidazole. A review of its use in rosacea.
    McClellan KJ; Noble S
    Am J Clin Dermatol; 2000; 1(3):191-9. PubMed ID: 11702300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S; Czernielewski J; Baltas E
    J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in pharmacotherapy for rosacea: what is the current state of the art?
    Dall'Oglio F; Nasca MR; Gerbino C; Micali G
    Expert Opin Pharmacother; 2022 Nov; 23(16):1845-1854. PubMed ID: 36330970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosacea: An Update in Diagnosis, Classification and Management.
    Kang CN; Shah M; Tan J
    Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rosacea and Demodex].
    Rufli T
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):585-6. PubMed ID: 16220610
    [No Abstract]   [Full Text] [Related]  

  • 59. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.
    Taieb A; Khemis A; Ruzicka T; Barańska-Rybak W; Berth-Jones J; Schauber J; Briantais P; Jacovella J; Passeron T;
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):829-36. PubMed ID: 26691278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
    Kuang AW; DuBois J; Attar M; Ahluwalia G
    J Drugs Dermatol; 2018 Feb; 17(2):213-220. PubMed ID: 29462230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.